埃索诺菲尔带炎:新的发展和未来的方向
Michelle Huynh1, Emily Bogdanski1, Taylor Fleshman2
1College of Medicine, The Ohio State University, Columbus, Ohio, USA.
乙酸性膜炎 (EF) 是一种罕见的自身免疫性疾病,具有诊断上的挑战,并且经常抵制像皮质类固醇这样的标准治疗. 较新的生物疗法为管理这种疾病和改善患者的结果提供了希望.
科学领域:
- 类风湿病学 类风湿病学
- 自免疫性疾病 自免疫性疾病
- 结合组织疾病 结合组织疾病
背景情况:
- 乙性带炎 (EF),或舒尔曼病,是一种罕见的自身免疫性硬化结缔组织疾病.
- 它的发病因子尚未完全理解,但涉及纤维细胞活性和与乙氨基酸相关的IL-5等白细胞间蛋白.
- 触发因素可能包括运动,创伤,感染或药物,尽管它通常是特异性的.
研究的目的:
- 为临床医生提供有关EF的诊断和管理的当前知识的全面摘要.
- 以突出诊断挑战和治疗选择,以酸性带炎.
- 审查了解和治疗这种罕见疾病的最新进展.
主要方法:
- 目前关于eosinophilic fasciitis的文献的综述.
- 诊断工作的分析,包括血液检查,活检,核磁共振和超声波.
- 评估治疗策略,包括传统和生物疗法.
主要成果:
- EF经常被误诊为其他硬化性疾病.
- 皮质类固醇和甲醇是常见的治疗方法,但许多患者是耐火的.
- 生物疗法在耐治疗病例中表现有前途,导致部分疾病解决.
结论:
- 精确诊断EF需要彻底的检查,活检作为黄金标准.
- 许多EF患者对传统治疗没有反应,需要替代疗法.
- 进一步的研究对于理解EF病原体,早期诊断和评估新疗法至关重要.
更多相关视频
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
05:45In Vivo Two-Color 2-Photon Imaging of Genetically-Tagged Reporter Cells in the Skin
Published on: July 11, 2019
相关概念视频
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
